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Abstract
Background: Chronic heart failure (CHF) is a chronic debilitating condition with economic consequences, mostly
because of frequent hospitalisations. Physical activity and adequate self-management capacity are important risk
reduction strategies in the management of CHF. The Home-Heart-Walk is a self-monitoring intervention. This model
of intervention has adapted the 6-minute walk test as a home-based activity that is self-administered and can be
used for monitoring physical functional capacity in people with CHF. The aim of the Home-Heart-Walk program is
to promote adherence to physical activity recommendations and improving self-management in people with CHF.
Methods/Design: A randomised controlled trial is being conducted in English speaking people with CHF in four
hospitals in Sydney, Australia. Individuals diagnosed with CHF, in New York Heart Association Functional Class II or
III, with a previous admission to hospital for CHF are eligible to participate. Based on a previous CHF study and a
loss to follow-up of 10%, 166 participants are required to be able to detect a 12-point difference in the study
primary endpoint (SF-36 physical function domain).
All enrolled participant receive an information session with a cardiovascular nurse. This information session covers
key self-management components of CHF: daily weight; diet (salt reduction); medication adherence; and physical
activity. Participants are randomised to either intervention or control group through the study randomisation
centre after baseline questionnaires and assessment are completed. For people in the intervention group, the
research nurse also explains the weekly Home-Heart-Walk protocol. All participants receive monthly phone calls
from a research coordinator for six months, and outcome measures are conducted at one, three and six months.
The primary outcome of the trial is the physical functioning domain of quality of life, measured by the physical
functioning subscale of the Medical Outcome Study Short Form -36. Secondary outcomes include physical
functional capacity measured by the standard six minute walk test, self-management capacity, health related
quality of life measured by Medical Outcome Study Short Form -36 and Minnesota Living With Heart Failure
Questionnaire, self-efficacy and self-care behaviour.
Discussion: A self-monitoring intervention that can improve individual’s exercise self-efficacy, self-management
capacity could have potential significance in improving the management of people with chronic heart failure in
community settings.
Trial Registration: Australian New Zealand Clinical Trial Registry 12609000437268
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Chronic heart failure (CHF) is a prevalent and debilitat-
ing condition and is most common in the elderly popu-
lation. Apart from the symptoms that individuals suffer
and the burden on their families, this condition poses a
substantial economic burden for the wider society [1,2].
It is estimated that CHF costs Australia AUD$1 billion
annually, with the bulk of these costs related to hospita-
lization [3]. Studies have shown that at least 40% of
readmissions to hospital for CHF are due to non-com-
pliance with treatment recommendations and inade-
quate patient information [4]. Although physical activity
is important and beneficial in the management of CHF,
many individuals consider that adhering to physical
activity recommendations is harder compared to imple-
menting strategies related to medications, dietary modi-
fications or fluid restriction [5].
The theoretical concept underpinning adherence to
physical activity is self-efficacy, which is the central con-
cept of self-management[6]. Individuals’ exercise self-
efficacy determines, in part, an individual’s ability to
initiate and sustain an exercise program [6]. Because the
benefits of physical activity are often not immediately
felt, this can be a barrier to sustainable behavior change.
Without prompted monitoring of progress, the impor-
tance and usefulness of physical activity is likely to be
overlooked. In addition, while many people with CHF are
managing in the community, monitoring of physical
functional capacity is most often undertaken in a clinical
environment where it requires well-trained staff and
equipment. Hospitalisation for CHF can occur when
individuals fail to recognise the signs and symptoms of
deteriorating physical function. Without adequate knowl-
edge and support, signs and symptoms such as shortness
of breath, weight gain or increasing fatigue can be disre-
garded [7]. Self-monitoring is one important but often
under-utilised self-management behaviors [8,9].
With the aim of assisting individuals and clinicians to
monitor and promote physical activity, we developed the
Home-Heart-Walk (HHW). The HHW has been devel-
oped based on the principle of self-efficacy and the
mechanistic elements of the 6MWT [10]. The HHW is
a self-administered, modified 6MWT. We chose to base
the HHW protocol on the 6MWT over other exercise
tests because of its simple, safe and inexpensive charac-
teristics and the ability to consider data sharing in the
future. The HHW program is a structured, self-monitor-
ing exercise program, which incorporates regular HHW
and telephone follow-up. After developing the HHW
prototype, we have assessed the correlation of the
HHW distance and the 6MWT distance in a group of
13 healthy adult (age 23 to 59) and the reliability and
feasibility in a group of 29 cardiac rehabilitation
participants[11]. The correlation between the two tests
distances was r = 0.81 [11]. The intra-class correlation
coefficient of the test distance over a 7 day period was
0.98 and the inter-rater correlation was almost perfect (r
= 0.99) [12]. Given the impact that regular monitoring
of the HHW could have on the management of CHF, a
randomized controlled trial to assess the ability of the
HHW to promote self-management and exercise self-
efficacy was devised.
Intervention
Based on a 6MWT literature review, [10] our research
team has modified the 6MWT to a home-based, self-
administered monitoring tool for functional capacity.
According to American Thoracic Society 6MWT guide-
line, a 30 meter long walking track is required. However,
a 30 meter long walking track is rarely feasible in a
home environment. In the HHW, walking is performed
alongside a 5-meter length of rope (marked in 1-meter
gradations) on a flat hard surface free of obstacles. The
purpose of the HHW is to cover as much distance as
possible in 6 minutes (Figure 1). In parallel with the
6MWT, stopping and resting were allowed during
the HHW test. However, standard encouragement using
Figure 1 Illustration of the walking track. Source:(Du, H. et al. 2009).
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during the HHW protocol. As a self-administered tool,
a lap counter was used to assist the individual to count
the number of full laps walked during the test. A timer
with a countdown function was used to time the six
minutes. Investigators calculate the distance covered
during the HHW test after the study is completed (Laps
walked × distance (in meters) per lap + partial lap).
The HHW program is based on a SMART concept
which is Simple, Measurable, Achievable, Realistic/rele-
vant and Timed, that assists to improve individuals exer-
cise self-efficacy [11]. When telephone support is
incorporated, the Home-Heart-Walk program could be
an effective intervention to assist people to recognize
and response to any functional changes, thereby improv-
ing their self-management capacity.
Aim
The study aims to evaluate the effect of the HHW pro-
gram on exercise self-efficacy and self-management in
people with stable CHF. The rationale for this approach
is Firstly, this approach seeks to promote physical activ-
ity-any bodily movement produced by skeletal muscles
that result in energy expenditure[13] using a method
that is accurate and reproducible. Secondly,i tp r o v i d e s
a measurement tool whereby individuals and their clini-
cians can monitor their condition. Thirdly, it may
increase self-efficacy for physical activity which can
likely be translated to other self-care behaviours [14,15]
and fourthly, improve health related quality of life
(HRQoL) which includes the overall impact of a medical
condition on the physical, mental, and social well-being
of an individual [16].
Study design and duration
The HHW study is a multicentre, non-blinded, parallel
arm, randomized controlled trial. For each individual,
the study will last for 6 months, and recruitment to the
whole study is expected to be completed within twelve
months.
Selection criteria
The diagnosis of CHF is based on the Australian
National Heart Foundation/Cardiac Society of Australia
and New Zealand guidelines [17]. Individuals with diag-
nosed CHF; with a previous hospitalisation for CHF; in
New York Heart Association Functional Class (NYHA-
FC) II or III and approved by their clinicians for physi-
cal activity will be invited to participate. Individuals with
unstable angina pectoris; recent unexplained syncope;
resting heart rate greater than 120 beats per minute;
inability to perform the 6MWT; failure to give informed
consent or significant cognitive impairment will be
excluded from this study. (Table 1)
Recruitment and randomization
Sample Size Calculation
Based on a previous CHF study, to detect a 12-point differ-
ence in physical function on the Short Form-36 with a stan-
dard deviation of 20 points, we estimated a sample size of
74 per group is needed with a 2-sided 5% significance level
and 95% power. When taking into account a loss to follow-
up of 10%, 166 participants (83 per group) will be required.
Recruitment
Potential participants are identified at cardiac wards and
cardiac clinics at each of the study sites. Research nurses
explain the HHW study in detail to individuals who are
interested in the study and agree to be contacted by the
research nurse. Once consented, participants will
undergo a screening phase, which includes review of
their medical records, resting blood pressure and heart
rate for assessment of eligibility. The research team keeps
a study log where all screened potential participants are
recorded and the reason if they are not enrolled in the
study. These data will provide a breakdown of the overall
pool of patients we have accessed and the ability to iden-
tify reason for non-participation. The study design allows
for a period of 6 months follow-up per participant.
Consent Form
Participants are asked to provide written informed consent
to participate in this study after reading the Information
Sheet and having any questions answered appropriately.
Randomization
Participants are randomly assigned to either the inter-
vention or the control group after completion of base-
line questionnaire and assessment. Randomization is
undertaken using a central phone randomization centre
using computer generated random numbers.
Blinding
As the HHW is a self-administered intervention, blind-
ing of the participant and the researcher who conduct
telephone follow-up is not possible. However, three and
six month follow-ups and data analysis is undertaken by
an assessor blinded to treatment allocation.
Table 1 Inclusion and exclusion criteria
Inclusion Criteria Exclusion Criteria
Have had a previous hospitalisation for heart
failure
Unstable angina
pectoris
In New York Heart Association-Functional Class
II or III
Recent unexplained
syncope
Approval from responsible clinician to
participate in the Home-Heart-Walk program
Failure to give
informed consent
Resting HR greater
then 120
Inability to perform
6MWT
Significant cognitive
impairment
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Demographic information, clinical status, functional and
general health status as well as their self-management
capacity as shown in Table 2 will be collected for partici-
pants in both the intervention and control group. A brief
physical examination is carried out on all participants to
collect the following data: height; weight; waist circum-
ference; hip circumference; heart rate; blood pressure;
pulse oximetry; and a cardio-respiratory examination.
Study instruments
The 6MWT: distance walked on a standard 6MWT are
used to measuring physical functional capacity; [18]Eur-
opean Heart Failure Self-care Behaviour Scale is used to
measure self-care capacity; [19] The Minnesota Living
With Heart Failure Questionnaire and Medical Outcome
Study Short Form-36 are used to assess HRQoL; [20]
The individual’s level of physical activity is measured by
using the National Physical Activity Prescription Scale;
[13] and Bandura’s Exercise Self-efficacy Scale is used
for measuring level of exercise self-efficacy[21].
procedure
Individuals who participate in the study undergo a base-
line physical assessment, a standard 6MWT, and receive
an information session from a cardiac nurse on HF self-
management. They are also provided with National
Heart Foundation Consumer Resource Guide [22]. A
summary of study schemata is presented as Figure 2.
Intervention group
The intervention group receives instructions on under-
taking the HHW by the research nurse. They are given
specific instructions on the HHW and the research
nurse observes their competency in the technique. Par-
ticipants are asked to perform the HHW daily for the
following week to gain proficiency. On Day 2 the
research nurse calls them to clarify their understanding
of the procedure. The research nurse calls participants
on Day 7 to clarify any concerns and answers any
questions. Subsequently, participants in the interven-
tion group are asked to undertake the HHW at least
weekly, and record this information in the HHW pro-
gram diary. A monthly phone call is organized with
the participant.
Control group
Apart from an identical baseline information session, the
control group will also receive a monthly telephone call
from the research nurse.
Telephone follow-up
Participants in both intervention and control group will
receive monthly telephone calls from the research nurse.
During the telephone call, the research nurse will obtain
participants HHW distance for the past month for the
intervention group. Control group will just have a gen-
eral phone call to check if there is any change in their
condition, or any hospitalisation during the past month.
The study procedure for both intervention and control
group is summarized in Table 3
Study endpoints
Primary endpoint
Health outcome measure
The SF-36 will be used to assess the HRQoL[23].
Although the primary outcome will be physical func-
tioning subscale of the SF-36, all eight subscales of the
SF-36 will be measured. Items scores related to each
subscale are coded, summed and scaled from 0 (worst
possible health state) to 100 (best possible health state).
Secondary endpoints
Secondary endpoints include: distance walked on a stan-
dard 6MWT [18] European Heart Failure Self-care
Behaviour Scale; [19] Minnesota Living With Heart Fail-
ure Questionnaire; [20] National Physical Activity Pre-
scription Scale; [13] and Bandura’s Exercise Self-efficacy
Scale [21]. These measurements are administered at
baseline, three and six month follow-up.
Adverse event monitoring
For the purpose of this study a Serious Adverse Event
will be defined as any untoward medical occurrence
resulting in hospitalisation or prolongation of hospitali-
sation, or is life-threatening, or results in death or dis-
ability[24]. Adverse events will be defined as any
untoward occurrences in study participants, potentially
related to implementation of the study protocol. All ser-
ious adverse events will be reported to the Coordinating
Centre and the Human Research Ethics Committee
within 24 hours and adverse events within 7 days as
required.
Table 2 Study measurements for both intervention and
control group
Demographic profile: Age, sex, marital status, social support,
education, ethnicity, health care utilization
Clinical status: Type, presumed cause and duration of CHF,
NYHA Functional Class, current
pharmacological and non-pharmacological
treatment, waist and hip circumference, and
existing blood test results, existing
echocardiography results
Functional/general
health status:
The Six Minute Walk Test distance, National
Physical Activity Prescription-Likert scale and
SF-36, Minnesota Living With Heart failure
Questionnaire
Self-management: Bandura’s Exercise Self-efficacy Scale;
The European Heart Failure Self-care Behaviour
Scale
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Survey data will be coded and analysed using the Statistical
Package for the Social Sciences computer statistical soft-
ware. Continuous data with normal distribution will be
analysed using independent t test and Mann-Whitney U
test for non-normally distributed data. Association
between categorical data will be analysed using Chi-square
test. When comparing change of SF-36 subscale scores
over time within groups; between baseline and 6-month
follow-up, the Wilcoxon signed ranks test will be used. A
p value of < 0.05 will be considered statistically significant
and all tests will be two tailed. Data analysis will be super-
vised by a statistician who is not involved in screening,
recruitment and follow-up of study participants.
Ethical issues
The study will be conducted according to the principle of
the declaration of Helsinki (version 2004) and the National
Health and Medical Research Council Guidelines for the
ethical conduct of clinical research and ethical approval
has been obtained from the Curtin University [approval
number HR 170/2008] and the relevant clinical sites [St
Vincent’s Hospital, approval number 08/SVH/77].
Discussion
This HHW study is a novel approach to self-management
in CHF. Low adherence to health recommendations sug-
gest the need to explore ways of better promoting adher-
ence to clinical advice and develop innovative
interventions for monitoring and managing people with
CHF in community settings. If evaluated as being suc-
cessful, the HHW protocol can be readily incorporated
into the community based management of CHF. In parti-
cular it has the potential to reach the subgroup of CHF
population who have limited physical functional capacity
and are not appropriate for higher intensity physical
activity. At the same time, this self-monitoring
Figure 2 Home-Heart-Walk study schemata.
Table 3 Study procedures for both intervention and
control group.
Measure Baseline 3
Months
6
months
Clinical history, physical assessment and
health care utilisation
XXX
Sociodemographic data X
Self-Efficacy [21] X X X
6MWT [18] X X X
SF-36 [23] X X X
EHFScBS [19] X X X
MLWHFQ [20] X X X
Physical activity scale [13] X X X
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managing people living in areas where clinical based,
supervised programs are not easily accessible.
The use of self-reported instruments could be a
potential limitation of this study, because the risk of
over reporting or under reporting from the participants
and is likely to be evenly distributed between the rando-
mized groups. However, this is inevitable with any kind
of study using self-reporting instruments. The study
instruments and scoring will be discussed when report-
ing study findings. Enrolment of the 166 participants
will continue through 2010. After recruitment of the
166 participants, the baseline characteristics of the parti-
cipants will be analysed. Outcome assessment is pro-
jected to be completed by mid 2011.
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